NCT06662617 Analgesic Effect of M-TAPA and TAPB on Laparoscopic Cholesistectomy
| NCT ID | NCT06662617 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cumhuriyet University |
| Condition | Post Operative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2024-11-01 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cholecystectomy is the most frequently performed abdominal surgery in developed nations, with laparoscopic cholecystectomy being recognized as the gold standard technique for treating gallstones. The efficacy of TAP block for pain relief has been well-documented following laparoscopic cholecystectomy procedures. Recently, m-TAPA block has emerged as an alternative analgesic technique for abdominal surgeries. This study aims to evaluate and compare the effectiveness of these two analgesic methods in managing postoperative pain after laparoscopic cholecystectomy.
Eligibility Criteria
Inclusion Criteria: * Adult patients older than 18 years of age who underwent elective laparoscopic cholecystectomy under general anesthesia and were American Society of * Anesthesiologists (ASA) I-II-III according to the ASA risk classification. Exclusion Criteria: * Patients who did not give consent, * patients with coagulopathy, * patients with signs of infection at the block application site, * patients using anticoagulants, * patients with local anesthetic drug allergies, * patients undergoing open surgery, * patients with unstable hemodynamics, * patients who could not cooperate during postoperative pain assessment
Frequently Asked Questions
Who can join the NCT06662617 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06662617 currently recruiting?
Yes, NCT06662617 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cumhuriyet University to inquire about joining.
Where is the NCT06662617 trial being conducted?
This trial is being conducted at Sivas, Turkey (Türkiye).
Who is sponsoring the NCT06662617 clinical trial?
NCT06662617 is sponsored by Cumhuriyet University. The trial plans to enroll 12 participants.